Export

Azathioprine
Essential medicine status
General description

INN
Azathioprine
ATC codes
L04AX01
Medicine type
Chemical agent
EML status history
Added in 1997 (TRS 882) for Psoriatic arthritis
Application rejected in 2015 (TRS 994) for Relapsing-remitting multiple sclerosis
Wikipedia
Azathioprine
DrugBank
Azathioprine
Recommendations
Section
Immunomodulators for non-malignant disease
  • Parenteral > General injections > IV: 100 mg in vial powder for injection (as sodium salt); 50 mg in vial powder for injection (as sodium salt)
  • Oral > Liquid: 10 mg per mL
  • Oral > Solid > tablet: 50 mg (scored); 25 mg
  • Oral > Solid: 50 mg
Indications
Failure or rejection of transplanted organs or tissues Relapsing-remitting multiple sclerosis
Section
Disease-modifying anti-rheumatic drugs (DMARDs)
  • Oral > Solid: 50 mg
Indications
Rheumatoid arthritis, serology unspecified Psoriatic arthritis